glp-1 kidney Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic disease: an approach for the nephrologist Potential kidney-protective and other effects

Because topiramate alone is not FDA-approved for weight loss, there is no official FDA-recommended dosage for this off-label use

They can help support hydration, skin health, energy levels, immune function, and overall wellness

Available from: MacFarquhar JK, Broussard DL, Melstrom P, Hutchinson R, Wolkin A, Martin C et al (2010) Acute selenium toxicity associated with a dietary supplement

It is an investigational triple agonist that targets GIP, GLP-1, and glucagon receptors

But research currently lags behind the trend, with the evidence around tirzepatides effectiveness based on therapeutic doses of at least 2mg